Skip to main content
Top
Published in: BMC Dermatology 1/2012

Open Access 01-12-2012 | Research article

Characterization of a unique technique for culturing primary adult human epithelial progenitor/“stem cells”

Authors: Cynthia Luz Marcelo, Antonio Peramo, Amala Ambati, Stephen E Feinberg

Published in: BMC Dermatology | Issue 1/2012

Login to get access

Abstract

Background

Primary keratinocytes derived from epidermis, oral mucosa, and urothelium are used in construction of cell based wound healing devices and in regenerative medicine. This study presents in vitro technology that rapidly expands keratinocytes in culture by growing monolayers under large volumes of serum-free, essential fatty acid free, low calcium medium that is replaced every 24 hrs.

Methods

Primary cell cultures were produced from epidermal skin, oral mucosa and ureter by trypsinization of tissue. Cells were grown using Epilife medium with growth factors under high medium volumes. Once densely confluent, the keratinocyte monolayer produced cells in suspension in the overlying medium that can be harvested every 24 hrs. over a 7–10 day period. The cell suspension (approximately 8 X 105 cells/ml) is poured into a new flask to form another confluent monolayer over 2–4 days. This new culture, in turn produced additional cell suspensions that when serially passed expand the cell strain over 2–3 months, without the use of enzymes to split the cultures. The cell suspension, called e pithelial P op U p K eratinocytes (ePUKs) were analyzed for culture expansion, cell size and glucose utilization, attachment to carrier beads, micro-spheroid formation, induction of keratinocyte differentiation, and characterized by immunohistochemistry.

Results

The ePUKs expanded greatly in culture, attached to carrier beads, did not form micro-spheroids, used approximately 50% of medium glucose over 24 hrs., contained a greater portion of smaller diameter cells (8–10 microns), reverted to classical appearing cultures when returned to routine feeding schedules (48 hrs. and 15 ml/T-75 flask) and can be differentiated by either adding 1.2 mM medium calcium, or essential fatty acids. The ePUK cells are identified as cycling (Ki67 expressing) basal cells (p63, K14 expressing).

Conclusions

Using this primary culture technique, large quantities of epithelial cells can be generated without the use of the enzyme trypsin to split the cultures. The cells are small in diameter and have basal cell progenitor/”stem” (P/SC) cell characteristics induced by daily feeding with larger than normal medium volumes. The ePUK epithelial cells have the potential to be used in regenerative medicine and for basic studies of epithelia P/SC phenotype.
Appendix
Available only for authorised users
Literature
1.
go back to reference Oliveira AA, Hodges HM: Alzheimer's disease and neural transplantation as prospective cell therapy. Curr Alzheimer Res 2005, 2: 79–95. 10.2174/1567205052772759CrossRefPubMed Oliveira AA, Hodges HM: Alzheimer's disease and neural transplantation as prospective cell therapy. Curr Alzheimer Res 2005, 2: 79–95. 10.2174/1567205052772759CrossRefPubMed
2.
go back to reference Bavister BD, Wolf DP, Brenner CA: Challenges of primate embryonic stem cell research. Cloning Stem Cells 2005, 7: 82–94. 10.1089/clo.2005.7.82CrossRefPubMed Bavister BD, Wolf DP, Brenner CA: Challenges of primate embryonic stem cell research. Cloning Stem Cells 2005, 7: 82–94. 10.1089/clo.2005.7.82CrossRefPubMed
3.
4.
go back to reference Lei P, Andreadis ST: Efficient retroviral gene transfer to epidermal stem cells. Methods in Molecular Biol 2008, 433: 367–379. 10.1007/978-1-59745-237-3_22CrossRef Lei P, Andreadis ST: Efficient retroviral gene transfer to epidermal stem cells. Methods in Molecular Biol 2008, 433: 367–379. 10.1007/978-1-59745-237-3_22CrossRef
5.
go back to reference Hodgkinson CP, Gomez JA, Mirotsou M, Dzau VJ: Genetic engineering of mesenchymal stem cells and its application in human diseases therapy. Hum Gene Ther 2010, 21: 1513–1526. 10.1089/hum.2010.165CrossRefPubMedPubMedCentral Hodgkinson CP, Gomez JA, Mirotsou M, Dzau VJ: Genetic engineering of mesenchymal stem cells and its application in human diseases therapy. Hum Gene Ther 2010, 21: 1513–1526. 10.1089/hum.2010.165CrossRefPubMedPubMedCentral
6.
go back to reference Lister R, Pelizola M, Kida , Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR: Hotspots of aberrant epipenomic reprogramming in human induced pluirpotent stem cells. Nature 2011, 471: 68–73. 10.1038/nature09798CrossRefPubMedPubMedCentral Lister R, Pelizola M, Kida , Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR: Hotspots of aberrant epipenomic reprogramming in human induced pluirpotent stem cells. Nature 2011, 471: 68–73. 10.1038/nature09798CrossRefPubMedPubMedCentral
7.
go back to reference Cohen DE, Melton D: Turning straw into gold: directing cell fate for regenerative medicine. Nat Rev Genet 2011, 12: 243–252.CrossRefPubMed Cohen DE, Melton D: Turning straw into gold: directing cell fate for regenerative medicine. Nat Rev Genet 2011, 12: 243–252.CrossRefPubMed
8.
go back to reference Plath K, Lowry W: Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet 2011, 12: 255–265. 10.1038/ni.1993CrossRef Plath K, Lowry W: Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet 2011, 12: 255–265. 10.1038/ni.1993CrossRef
9.
go back to reference Grinnell KL, Bickenbach JR: Skin keratinocytes pre-treated with embryonic stem-cell conditioned medium or BMP4 can be directed to an alternative cell lineage. Cell Prolif 2007, 40: 685–705. 10.1111/j.1365-2184.2007.00464.xCrossRefPubMed Grinnell KL, Bickenbach JR: Skin keratinocytes pre-treated with embryonic stem-cell conditioned medium or BMP4 can be directed to an alternative cell lineage. Cell Prolif 2007, 40: 685–705. 10.1111/j.1365-2184.2007.00464.xCrossRefPubMed
10.
go back to reference Izumi K, Terashi H, Marcelo CL, Feinberg SE: Development and characterization of a tissue engineered oral mucosa equivalent produced in a serum-free culture system. J Dent Res 2000,79(3):798–805. 10.1177/00220345000790030301CrossRefPubMed Izumi K, Terashi H, Marcelo CL, Feinberg SE: Development and characterization of a tissue engineered oral mucosa equivalent produced in a serum-free culture system. J Dent Res 2000,79(3):798–805. 10.1177/00220345000790030301CrossRefPubMed
11.
go back to reference Marcelo CL, Duell EA, Rhodes , Dunham WR: In vitro model of essential fatty acid deficiency. J Invest Dermatol 1992, 99: 703–708. 10.1111/1523-1747.ep12614196CrossRefPubMed Marcelo CL, Duell EA, Rhodes , Dunham WR: In vitro model of essential fatty acid deficiency. J Invest Dermatol 1992, 99: 703–708. 10.1111/1523-1747.ep12614196CrossRefPubMed
12.
go back to reference Tseng-Rogenski S, Liebert M: Interleukin-8 is essential for normal urothelial cell survival. Am J Physiol Renal Physiol 2009, 297: 816–821. 10.1152/ajprenal.90733.2008CrossRef Tseng-Rogenski S, Liebert M: Interleukin-8 is essential for normal urothelial cell survival. Am J Physiol Renal Physiol 2009, 297: 816–821. 10.1152/ajprenal.90733.2008CrossRef
13.
go back to reference Yee YY, Goodwin JF: Evaluation of some factors influencing the o-Toluidine reaction with glucose. Anal Chem 1973, 45: 2162–2165. 10.1021/ac60335a030CrossRef Yee YY, Goodwin JF: Evaluation of some factors influencing the o-Toluidine reaction with glucose. Anal Chem 1973, 45: 2162–2165. 10.1021/ac60335a030CrossRef
14.
go back to reference Marcelo CL, Rhodes LM, Dunham WR: Normalization of essential fatty acid deficient keratinocytes by medium supplements requires palmitic acid. J Invest Dermatol 1994, 103: 564–568. 10.1111/1523-1747.ep12396864CrossRefPubMed Marcelo CL, Rhodes LM, Dunham WR: Normalization of essential fatty acid deficient keratinocytes by medium supplements requires palmitic acid. J Invest Dermatol 1994, 103: 564–568. 10.1111/1523-1747.ep12396864CrossRefPubMed
15.
go back to reference Barrandon Y, Green H: Cell size as a determinant of the clone-forming ability of human keratinocytes. Proc Natl Acad Sci USA 1985, 82: 5390–5394. 10.1073/pnas.82.16.5390CrossRefPubMedPubMedCentral Barrandon Y, Green H: Cell size as a determinant of the clone-forming ability of human keratinocytes. Proc Natl Acad Sci USA 1985, 82: 5390–5394. 10.1073/pnas.82.16.5390CrossRefPubMedPubMedCentral
16.
go back to reference Knagg H, Holland D, Morris C, Wood E, Cunliffe : Quantification of cellular proliferation in acne using the monoclonal antibody Ki-67. J Invest Dermatol 1994, 102: 89–92. 10.1111/1523-1747.ep12371738CrossRef Knagg H, Holland D, Morris C, Wood E, Cunliffe : Quantification of cellular proliferation in acne using the monoclonal antibody Ki-67. J Invest Dermatol 1994, 102: 89–92. 10.1111/1523-1747.ep12371738CrossRef
17.
go back to reference Pellegrini G, Dellambra R, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M: P63 identifies keratinocytes stem cells. PNAS USA 2001, 98: 3156–3161. 10.1073/pnas.061032098CrossRefPubMedPubMedCentral Pellegrini G, Dellambra R, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M: P63 identifies keratinocytes stem cells. PNAS USA 2001, 98: 3156–3161. 10.1073/pnas.061032098CrossRefPubMedPubMedCentral
18.
go back to reference Lane EB, Mclean WH: Keratins and skin disorders. J of Pathology 2004, 201: 355–366.CrossRef Lane EB, Mclean WH: Keratins and skin disorders. J of Pathology 2004, 201: 355–366.CrossRef
19.
go back to reference Mehrel T, Hohl D, Rothnagel J, Longley M, Bundman D, cheng C, Lichti U, Bisher M, Steven A, Steinert P, Yuspa S, Roop D: Identification of a major keratinocyte cell envelope protein, Loricrin. Cell 1990, 61: 1103–1112. 10.1016/0092-8674(90)90073-NCrossRefPubMed Mehrel T, Hohl D, Rothnagel J, Longley M, Bundman D, cheng C, Lichti U, Bisher M, Steven A, Steinert P, Yuspa S, Roop D: Identification of a major keratinocyte cell envelope protein, Loricrin. Cell 1990, 61: 1103–1112. 10.1016/0092-8674(90)90073-NCrossRefPubMed
20.
go back to reference Lee CH, Marekov L, Kin S-Y, Brahim J, Park MH, Steinert PM: Small proline-rich protein 1 is the major component of cell envelope of normal human oral keratinocytes. FEBS 2000, 477: 268–271. 10.1016/S0014-5793(00)01806-8CrossRef Lee CH, Marekov L, Kin S-Y, Brahim J, Park MH, Steinert PM: Small proline-rich protein 1 is the major component of cell envelope of normal human oral keratinocytes. FEBS 2000, 477: 268–271. 10.1016/S0014-5793(00)01806-8CrossRef
21.
go back to reference Webb A, Li A, Kaur P: Location and phenotype of human adult keratinocyte strain cells of the skin. Differentiation 2004, 72: 387–395. 10.1111/j.1432-0436.2004.07208005.xCrossRefPubMed Webb A, Li A, Kaur P: Location and phenotype of human adult keratinocyte strain cells of the skin. Differentiation 2004, 72: 387–395. 10.1111/j.1432-0436.2004.07208005.xCrossRefPubMed
22.
go back to reference Watt F, Green H: Involucrin synthesis correlated with cell size in human epidermal cultures. J Cell Biol 1981, 90: 738–742. 10.1083/jcb.90.3.738CrossRefPubMed Watt F, Green H: Involucrin synthesis correlated with cell size in human epidermal cultures. J Cell Biol 1981, 90: 738–742. 10.1083/jcb.90.3.738CrossRefPubMed
23.
go back to reference Watt FM, Boukamp P, Horning J, Fusenig NE: Effect of growth environment on spatial expression of involucrin by human epidermal keratinocytes. Arch Dermatol Res 1987, 279: 335–340. 10.1007/BF00431227CrossRefPubMed Watt FM, Boukamp P, Horning J, Fusenig NE: Effect of growth environment on spatial expression of involucrin by human epidermal keratinocytes. Arch Dermatol Res 1987, 279: 335–340. 10.1007/BF00431227CrossRefPubMed
24.
go back to reference Rees R, Marcelo CL, et al.: Wound treatment with keratinocytes on a solid support enclosed in a porous material. 1999. Patent Number 5,972,332 Rees R, Marcelo CL, et al.: Wound treatment with keratinocytes on a solid support enclosed in a porous material. 1999. Patent Number 5,972,332
25.
go back to reference Rees R, Marcelo CL, et al.: System for the treatment of wounds. 2001. Patent number 6,197,330 Rees R, Marcelo CL, et al.: System for the treatment of wounds. 2001. Patent number 6,197,330
26.
go back to reference Rees R, Marcelo CL, et al.: Methods and compositions for the treatment of wounds. 2001. Patent number 6,299,898 Rees R, Marcelo CL, et al.: Methods and compositions for the treatment of wounds. 2001. Patent number 6,299,898
27.
go back to reference Lin RZ, Chang H: Recent advances in three-dimensional multicellular spheroid culture for biomedical Research. Biotechnol J 2008, 3: 1172–1184. 10.1002/biot.200700228CrossRefPubMed Lin RZ, Chang H: Recent advances in three-dimensional multicellular spheroid culture for biomedical Research. Biotechnol J 2008, 3: 1172–1184. 10.1002/biot.200700228CrossRefPubMed
28.
go back to reference Zoncu R, Efeyan A, Sabatini DM: mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Review/molecular Biology 2011, 12: 1–35. Zoncu R, Efeyan A, Sabatini DM: mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Review/molecular Biology 2011, 12: 1–35.
29.
go back to reference Izumi K, Inok Y, Fujimori H, Marcelo CL, Feinberg SE: Pharmacological retention of oral mucosa progenitor/stem cells. J Dent Res 2009, 88: 1113–1118. 10.1177/0022034509350559CrossRefPubMedPubMedCentral Izumi K, Inok Y, Fujimori H, Marcelo CL, Feinberg SE: Pharmacological retention of oral mucosa progenitor/stem cells. J Dent Res 2009, 88: 1113–1118. 10.1177/0022034509350559CrossRefPubMedPubMedCentral
30.
go back to reference Chaffer C, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, Brooks M, Reinhardt F, Su Y, Polyak K, Arendt LM, Kuperwasser C, Bierie B, Weinberg RA: Normal and neoplastic non-stem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA 2011, 19: 7950–7955.CrossRef Chaffer C, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, Brooks M, Reinhardt F, Su Y, Polyak K, Arendt LM, Kuperwasser C, Bierie B, Weinberg RA: Normal and neoplastic non-stem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA 2011, 19: 7950–7955.CrossRef
31.
go back to reference Aasen T, Raya A, Barrero M, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilić J, Pekarik V, Tiscornia G, Edel M, Boué S, Izpisúa Belmonte JC: Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008, 11: 1278–1284. Aasen T, Raya A, Barrero M, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilić J, Pekarik V, Tiscornia G, Edel M, Boué S, Izpisúa Belmonte JC: Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008, 11: 1278–1284.
Metadata
Title
Characterization of a unique technique for culturing primary adult human epithelial progenitor/“stem cells”
Authors
Cynthia Luz Marcelo
Antonio Peramo
Amala Ambati
Stephen E Feinberg
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Dermatology / Issue 1/2012
Electronic ISSN: 1471-5945
DOI
https://doi.org/10.1186/1471-5945-12-8

Other articles of this Issue 1/2012

BMC Dermatology 1/2012 Go to the issue